Cargando…

Editorial Comment from Dr Sekino and Dr Hinata to A case of metastatic treatment emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy

Detalles Bibliográficos
Autores principales: Sekino, Yohei, Hinata, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626326/
https://www.ncbi.nlm.nih.gov/pubmed/36341205
http://dx.doi.org/10.1002/iju5.12507
_version_ 1784822705375150080
author Sekino, Yohei
Hinata, Nobuyuki
author_facet Sekino, Yohei
Hinata, Nobuyuki
author_sort Sekino, Yohei
collection PubMed
description
format Online
Article
Text
id pubmed-9626326
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96263262022-11-03 Editorial Comment from Dr Sekino and Dr Hinata to A case of metastatic treatment emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy Sekino, Yohei Hinata, Nobuyuki IJU Case Rep Editorial Comments John Wiley and Sons Inc. 2022-07-15 /pmc/articles/PMC9626326/ /pubmed/36341205 http://dx.doi.org/10.1002/iju5.12507 Text en © 2022 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial Comments
Sekino, Yohei
Hinata, Nobuyuki
Editorial Comment from Dr Sekino and Dr Hinata to A case of metastatic treatment emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy
title Editorial Comment from Dr Sekino and Dr Hinata to A case of metastatic treatment emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy
title_full Editorial Comment from Dr Sekino and Dr Hinata to A case of metastatic treatment emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy
title_fullStr Editorial Comment from Dr Sekino and Dr Hinata to A case of metastatic treatment emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy
title_full_unstemmed Editorial Comment from Dr Sekino and Dr Hinata to A case of metastatic treatment emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy
title_short Editorial Comment from Dr Sekino and Dr Hinata to A case of metastatic treatment emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy
title_sort editorial comment from dr sekino and dr hinata to a case of metastatic treatment emergent small cell/neuroendocrine prostate cancer with brca2 mutation diagnosed by liver biopsy
topic Editorial Comments
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626326/
https://www.ncbi.nlm.nih.gov/pubmed/36341205
http://dx.doi.org/10.1002/iju5.12507
work_keys_str_mv AT sekinoyohei editorialcommentfromdrsekinoanddrhinatatoacaseofmetastatictreatmentemergentsmallcellneuroendocrineprostatecancerwithbrca2mutationdiagnosedbyliverbiopsy
AT hinatanobuyuki editorialcommentfromdrsekinoanddrhinatatoacaseofmetastatictreatmentemergentsmallcellneuroendocrineprostatecancerwithbrca2mutationdiagnosedbyliverbiopsy